Torti, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 2.463
AS - Asia 1.609
EU - Europa 1.141
SA - Sud America 395
Continente sconosciuto - Info sul continente non disponibili 98
AF - Africa 46
OC - Oceania 3
Totale 5.755
Nazione #
US - Stati Uniti d'America 2.325
SG - Singapore 607
CN - Cina 345
BR - Brasile 315
IT - Italia 308
VN - Vietnam 194
DE - Germania 167
BD - Bangladesh 157
FR - Francia 147
SE - Svezia 131
CA - Canada 72
UA - Ucraina 66
GB - Regno Unito 64
JP - Giappone 61
PL - Polonia 57
IN - India 54
FI - Finlandia 53
IE - Irlanda 46
HK - Hong Kong 42
ID - Indonesia 38
AR - Argentina 34
MX - Messico 26
RU - Federazione Russa 23
KR - Corea 21
IQ - Iraq 20
NL - Olanda 20
EC - Ecuador 16
TR - Turchia 16
ZA - Sudafrica 16
CO - Colombia 12
AT - Austria 10
ES - Italia 10
JM - Giamaica 10
CR - Costa Rica 8
HN - Honduras 7
LT - Lituania 7
PH - Filippine 7
BE - Belgio 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
MA - Marocco 5
PK - Pakistan 5
DO - Repubblica Dominicana 4
KE - Kenya 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
CH - Svizzera 3
CL - Cile 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
MY - Malesia 3
NG - Nigeria 3
PY - Paraguay 3
TN - Tunisia 3
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BN - Brunei Darussalam 2
ET - Etiopia 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
ME - Montenegro 2
RO - Romania 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
LI - Liechtenstein 1
LV - Lettonia 1
LY - Libia 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.654
Città #
San Jose 369
Singapore 306
Ashburn 276
Chandler 162
Houston 80
Council Bluffs 74
Ho Chi Minh City 72
New York 67
Hefei 66
Beijing 64
Milan 58
Tokyo 55
Hanoi 49
Los Angeles 45
Redmond 45
Dublin 43
Lauterbourg 43
Kraków 42
Rome 41
São Paulo 35
Hong Kong 33
Jacksonville 33
Santa Clara 32
San Mateo 31
Jakarta 30
The Dalles 28
Boston 26
Helsinki 25
Cattolica 23
Buffalo 22
Frankfurt am Main 21
Seoul 20
Wilmington 20
Dallas 19
Phoenix 19
Kent 18
Brooklyn 17
Nanjing 17
Orem 17
Chicago 16
Montreal 15
Seattle 15
Boardman 14
Chennai 14
Paris 13
Princeton 13
Dearborn 12
Lawrence 12
Lappeenranta 11
Nanchang 11
Rio de Janeiro 11
Warsaw 11
Denver 10
Mexico City 10
Munich 10
Roubaix 10
St Louis 10
Guayaquil 9
Haiphong 9
Marseille 9
Poplar 9
Stockholm 9
Toronto 9
Atlanta 8
Düsseldorf 8
Moscow 8
Naples 8
Norwalk 8
Philadelphia 8
Redwood City 8
Amsterdam 7
Belo Horizonte 7
Bexley 7
Johannesburg 7
Kingston 7
Las Vegas 7
London 7
Mumbai 7
Pune 7
Woodbridge 7
Ann Arbor 6
Brasília 6
Brussels 6
Catania 6
Figino 6
Hải Dương 6
Nuremberg 6
Ottawa 6
San Francisco 6
Shanghai 6
Ankara 5
Biên Hòa 5
Bogotá 5
Bremen 5
Curitiba 5
Dhaka 5
Fuzhou 5
Jinan 5
Manaus 5
Monza 5
Totale 2.951
Nome #
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 270
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort) 192
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 185
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 168
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 168
Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe 150
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons 142
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 142
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 142
Utility, acceptability and applicability of a nucleic acid amplification test in comparison with a syndromic approach in the management of sexually transmitted diseases at Mulago National Referral Hospital in Uganda (ASTRHA): Protocol for an open-label, randomised controlled trial 141
Liver fibrosis progression and clinical outcomes are intertwined: Role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCVcoinfected patients with detectable HCV-RNA A MASTER cohort study 141
A systematic review of dalbavancin efficacy as a sequential therapy for infective endocarditis 133
Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir: Results from clinical practice 131
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 131
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 130
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 125
Prolonged survival in HIV-associated Progressive Multifocal Leukoencephalopathy treated with Pembrolizumab: a case series on treatment and long-term follow-up 121
Natural NS5A inhibitor resistance associated substitutions in hepatitis C virus genotype 1 infected patients from Italy 115
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 111
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 108
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 105
Real World Data from an Italian Outpatient Clinical Setting and from Home Care Assistance of Treatment-Experienced PWH Switching to CAB + RPV Regimen: A Prospective Observational Study 104
Assessing dengue seroprevalence among people living with HIV (PLWH) in rome, Italy: Insights from the 2023 Italian autochthonous outbreak 102
Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19 101
Survival in HIV-infected patients after a cancer diagnosis in the cART era: Results of an Italian multicenter study 101
Heteroresistance and clinical outcomes: knowledge gaps 98
Autochthonous dengue outbreak in Rome, Italy, in 2023 98
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience 97
Treatment with valacyclovir during pregnancy for prevention of congenital cytomegalovirus infection: a real-life multicenter Italian observational study 95
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors 92
Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received 88
Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy 88
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 88
Evolving phenotypes of non-hospitalized patients that indicate long COVID 87
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 86
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study 86
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 82
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 80
Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort 79
HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir 78
Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response 78
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 77
New advances in management and treatment of cardiac implantable electronic devices infections 76
Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis 75
The effect of primary drug resistance on CD4 cell decline and the viral load set-point in HIV positive individuals before the start of antiretroviral therapy 74
HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure 72
What Every Reader Should Know About Studies Using Electronic Health Record Data but May Be Afraid to Ask 65
Effect of an educational antimicrobial stewardship programme on antibiotic prescriptions' appropriateness in three medical units of a large university hospital: an interrupted time series analysis 32
Does it still make sense to talk about carbapenem-sparing? 26
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 24
How long is enough? Evidence gaps and research priorities for antibiotic duration in immunocompromised hosts 23
Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: Real-world data from the PRESTIGIO Registry 23
Capnocytophaga canimorsus spondylodiscitis: an unusual presentation of a zoonotic infection 22
Impact of a post-prescription audit and feedback antimicrobial stewardship intervention on inappropriate carbapenem prescribing: An interrupted time series analysis 22
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era 20
Management of infections caused by Gram-negative bacteria in severely immunocompromised hosts employing Outpatient Parenteral Antimicrobial Therapy (OPAT): Preliminary evidence from a real-world observational study 19
Successful treatment of pneumonia due to Mycobacterium goodii in a severely underweight 45-year-old woman: case report and review of literature 18
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 16
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 15
Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions 14
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 13
Real-World Application of Recommended Practices in Nocardiosis 13
The Use of Oritavancin as Consolidation Therapy for Infective Endocarditis Caused by Enterococcus spp 13
The three facets of the SARS-CoV-2 pandemic during the first two waves in the northern, central, and southern Italy 12
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium 12
Patterns of multi-drug resistant bacteria at first culture from patients admitted to a third level University hospital in Calabria from 2011 to 2014: implications for empirical therapy and infection control 11
Weight of Clinical and Social Determinants of Metabolic Syndrome in People Living with HIV 11
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 11
Evolution of in-hospital patient characteristics and predictors of death in the COVID-19 pandemic across four waves: are they moving targets with implications for patient care? 10
Knowledge of HIV infection and transmission: a knowledge, attitudes, beliefs and practices (KABP) survey among a sample of students at the “Magna Graecia”, University of Catanzaro 10
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 10
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae 9
Knowledge of Human Cytomegalovirus Infection and Prevention in Pregnant Women: A Baseline, Operational Survey 9
Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the “Magna Graecia” University Unit of Infectious Diseases: A Didascalic Review 8
Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC study 7
Is hand-grip another culprit for the risk of fractures in HIV-positive patients? 7
A case report ofSchistosoma haematobiuminfection in a pregnant migrant raises concerns about lack of screening policies 6
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? 6
The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real? 5
Totale 5.755
Categoria #
all - tutte 23.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022148 0 0 0 6 7 4 11 30 7 7 36 40
2022/2023413 62 61 31 48 36 50 13 36 50 4 13 9
2023/2024219 10 54 1 15 4 39 13 11 3 4 42 23
2024/2025755 5 10 47 9 38 19 51 35 70 72 205 194
2025/20262.618 357 119 220 409 367 98 315 103 126 143 184 177
2026/2027949 134 271 267 277 0 0 0 0 0 0 0 0
Totale 5.755